Study Looking at Biomarkers in Ovarian Cancer (NCT03419689)
Biomarker Discovery Project in High Grade Serous Ovarian Cancer
🩺 Plain-English Summary (8th-Grade Level)
This is a sample study that will collect biological samples (blood, tumor tissue, ascites, and/or other fluids) from gynecological cancer patients for biomarker research. In addition, the results of the testing done on the samples will be given to the participant's treating physician who may use the information to guide treatment decisions.
Who can join: Review the eligibility criteria below.
Location: Royal Victoria Regional Health Centre — Barrie, Ontario
Age range: 18 Years
🧪 Interventions in This Study
- Tumour tissue collection (PROCEDURE)
- Blood sample collection (PROCEDURE)
- Ascites Collection (PROCEDURE)
- Fluid Collection (PROCEDURE)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (7 Sites)
- Royal Victoria Regional Health Centre — Barrie, Ontario
- Juravinski Cancer Centre — Hamilton, Ontario
- Kingston Health Sciences Centre — Kingston, Ontario
- London Health Sciences Centre — London, Ontario
- The Ottawa Hospital Cancer Centre — Ottawa, Ontario
- Sunnybrook Health Sciences Centre — Toronto, Ontario
- Princess Margaret Cancer Centre — Toronto, Ontario
📞 Contact the Study Coordinator
Phone: (416) 946-2818
Email: amit.oza@uhn.ca
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Gynecologic Cancer
- Journey Ahead: Enhancing Coping and Communication for Women Diagnosed With Gynecological Cancer — New Brunswick, New Jersey
- Patient Related Outcomes for Gynecologic Radiation Oncology — Chapel Hill, North Carolina
- Optimizing Brachytherapy Application and Delivery With MRI Guidance for Gynecologic Cancer — Boston, Massachusetts
- Feasibility Study: IGNITE-TX (Identifying Individuals for Genetic Testing & Treatment) Intervention — Houston, Texas
- Impact of Cultural and Linguistic Backgrounds on Patient Care and Experience of Women With Gynecologic Malignancies — Toronto, Ontario
- Intraperitoneal FT536 in Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer — Minneapolis, Minnesota
Explore by condition: All Gynecologic Cancer clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.